SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01099 SINOPHARM

Trading 04-15 15:12:48

20.880

+0.500

+2.45%

High20.900	Low20.380	Vol2.30M
Open20.380	D1 Closing20.380	Amplitude2.55%
Mkt Cap65.17B	Tradable Cap28.02B	Total Shares3.12B
T/O47.67M	T/O Rate0.17%	Tradable Shares1.34B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"SINOPHARM","latestPrice":20.88,"timestamp":1776237164384,"preClose":20.38,"halted":0,"volume":2296663,"delay":0,"changeRate":0.02453385672227674,"floatShares":1341810740,"shares":3121000000,"eps":2.6332918247076895,"marketStatus":"Trading","change":0.5,"latestTime":"04-15 15:12:48","open":20.38,"high":20.9,"low":20.38,"amount":47671736,"amplitude":0.025515,"askPrice":20.88,"askSize":25200,"bidPrice":20.86,"bidSize":86400,"shortable":3,"etf":0,"ttmEps":2.6332918247076895,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1776240600000},"marketStatusCode":2,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":20.38,"dividendRate":0.037373,"openAndCloseTimeList":[[1776216600000,1776225600000],[1776229200000,1776240000000]],"volumeRatio":0.523805,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.2982,"impliedVolPercentile":0.6762},"requestUrl":"/m/hq/s/01099/tweets","defaultTab":"tweets","newsList":[{"id":"2627943399","title":"Sinopharm Group  Stock Falls 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2627943399","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627943399?lang=en_us&edition=fundamental","pubTime":"2026-04-13 16:31","pubTimestamp":1776069060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 2.9% to 20.32 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25660.85.This was the stock's third consecutive day of losses.Sinopharm Group Co. Ltd. closed 9.0% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.8%.Trading volume totaled 5.8 million shares, compared to the 50-day average of 5.8 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU1115378108.SGD","BK4175","LU0640798160.USD","BK1197","SHTDY","BK1515","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626119848","title":"Sinopharm schedules board meeting to review unaudited first-quarter results","url":"https://stock-news.laohu8.com/highlight/detail?id=2626119848","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626119848?lang=en_us&edition=fundamental","pubTime":"2026-04-10 16:43","pubTimestamp":1775810618,"startTime":"0","endTime":"0","summary":"Sinopharm scheduled board meeting for April 24, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL4rs8xy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1197","LU1115378108.SGD","BK1515","BK1500","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626902279","title":"Sinopharm Group  Stock Slips 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2626902279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626902279?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:36","pubTimestamp":1775723760,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.0% to 21.08 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.5% to 25752.40.The stock's fall snapped a three-day winning streak.Sinopharm Group Co. Ltd. closed 5.6% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.8%.Trading volume totaled 3.6 million shares, compared to the 50-day average of 5.9 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1115378108.SGD","01099","BK4175","BK1500","SHTDY","BK1515","BK1197","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624571953","title":"Sinopharm Group  Stock Advances 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2624571953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624571953?lang=en_us&edition=fundamental","pubTime":"2026-04-02 16:32","pubTimestamp":1775118720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 2.0% to 20.92 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.7% to 25116.53.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 6.4% short of its 52-week high of HK$22.34, which the company reached Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 1.7%.Trading volume totaled 3.8 million shares, compared to the 50-day average of 5.9 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU1115378108.SGD","BK4175","LU0640798160.USD","BK1197","SHTDY","BK1515","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195916396","title":"Sinopharm Accord FY2025 Net Profit Jumps 76.80% to RMB1.14 Billion Despite Slight Revenue Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=1195916396","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195916396?lang=en_us&edition=fundamental","pubTime":"2026-04-01 22:23","pubTimestamp":1775053380,"startTime":"0","endTime":"0","summary":"Sinopharm Group Co. Ltd. (Sinopharm) disclosed that its Shenzhen-listed subsidiary, China National Accord Medicines Corporation Ltd. (Sinopharm Accord), recorded a robust earnings rebound for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624751439","title":"Sinopharm Accord net profit attributable to shareholders jumps 76.8% to RMB 1.136 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2624751439","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624751439?lang=en_us&edition=fundamental","pubTime":"2026-04-01 22:13","pubTimestamp":1775052821,"startTime":"0","endTime":"0","summary":"Sinopharm unit Sinopharm Accord posted FY2025 net profit attributable to shareholders of RMB 1.136 billion, up 76.80%.Operating cash flow fell 49.91% to RMB 1.64 billion.Asset impairment provisions for goodwill and intangible assets dropped RMB 686 million.Total assets rose 3.24% to RMB 49.1 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL3P9Ffy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0010","BK0196","BK1197","000028","BK0188","BK1515","BK0175","LU0640798160.USD","BK1500","LU1115378108.SGD","BK0028","BK0250","01099","BK0082","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176011249","title":"SINOPHARM Receives Additional Investment from Lazard Asset Management LLC Involving 2.1 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1176011249","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176011249?lang=en_us&edition=fundamental","pubTime":"2026-03-30 07:40","pubTimestamp":1774827632,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on March 24, Lazard Asset Management LLC increased its stake in SINOPHARM (01099) by 2,096,025 shares. The transaction was executed at...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1197","LU1115378108.SGD","BK1515","01099","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622004078","title":"A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004078","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004078?lang=en_us&edition=fundamental","pubTime":"2026-03-28 10:08","pubTimestamp":1774663704,"startTime":"0","endTime":"0","summary":"Sinopharm Group (SEHK:1099) has drawn investor attention after its board proposed a final dividend of CN¥0.69 per share for 2025, totaling about CN¥2.15b, subject to approval at the June 18 AGM.\nSee our latest analysis for Sinopharm Group.\nThe proposed dividend comes after a period where momentum has been mixed, with a 30 day share price return showing a decline of 7.38% and a one year total shareholder return of 15.09%. This suggests recent weakness against a stronger longer term outcome.\nIf...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/a-look-at-sinopharm-group-sehk1099-valuation-after-the-propo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/a-look-at-sinopharm-group-sehk1099-valuation-after-the-propo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01099","LU1115378108.SGD","BK1515","BK1500","LU0640798160.USD","DCF","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149661222","title":"SINOPHARM Establishes New Subsidiary in Xiong'an","url":"https://stock-news.laohu8.com/highlight/detail?id=1149661222","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149661222?lang=en_us&edition=fundamental","pubTime":"2026-03-28 06:50","pubTimestamp":1774651846,"startTime":"0","endTime":"0","summary":"On March 27, the inauguration ceremony for SINOPHARM (Xiong'an) Co., Ltd. and a conference on the development of the pharmaceutical industry under the guidance of the Healthy China initiative were...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1115378108.SGD","BK1197","01099","LU0640798160.USD","BK1515","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153636810","title":"Lazard Asset Management Increases Stake in SINOPHARM by Approximately 2.1 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1153636810","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153636810?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:41","pubTimestamp":1774611703,"startTime":"0","endTime":"0","summary":"On March 24, Lazard Asset Management LLC purchased an additional 2,096,025 shares of SINOPHARM (01099) at a price of HK$19.5897 per share. The total transaction value amounted to approximately...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1500","BK1515","01099","LU1115378108.SGD","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621052073","title":"Sinopharm Group  Stock Falls 3.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2621052073","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621052073?lang=en_us&edition=fundamental","pubTime":"2026-03-24 16:32","pubTimestamp":1774341120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. shed 3.6% to 19.68 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 2.8% to 25063.71.This was the stock's second consecutive day of losses.Sinopharm Group Co. Ltd. closed 12% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 1.6%.Trading volume totaled 8.2 million shares, compared to the 50-day average of 5.7 million shares.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1500","LU0640798160.USD","BK1515","LU1115378108.SGD","SHTDY","BK1197","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192405184","title":"UBS Slightly Raises SINOPHARM (01099) Target Price to HK$25.7, Anticipates Stronger Revenue Growth This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1192405184","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192405184?lang=en_us&edition=fundamental","pubTime":"2026-03-24 14:40","pubTimestamp":1774334419,"startTime":"0","endTime":"0","summary":"UBS released a research report indicating that SINOPHARM (01099) reported total revenue of CNY 575.1 billion for 2025, a decrease of 1.6% year-on-year. Profit attributable to shareholders was CNY...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","LU1115378108.SGD","BK1500","01099","BK1197","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113156654","title":"SINOPHARM Shares Drop Nearly 5% Following Annual Results; Citi Trims Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1113156654","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113156654?lang=en_us&edition=fundamental","pubTime":"2026-03-24 11:58","pubTimestamp":1774324710,"startTime":"0","endTime":"0","summary":"SINOPHARM (01099) fell nearly 5%, declining 4.8% to HK$19.44 at the time of writing, with a turnover of HK$56.2142 million. The company released its annual results for 2025, reporting revenue of RMB...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU1366192091.USD","LU0320765646.SGD","LU0648001328.SGD","BK1515","LU0128525689.USD","LU1668664300.SGD","BK4588","VXUS","LU0162691827.USD","BK4585","LU1115378108.SGD","BK4504","LU2125154935.USD","LU0170899867.USD","LU1244550577.SGD","LU0130517989.USD","LU1791807156.HKD","LU0310800965.SGD","LU2417539215.USD","LU2360032135.SGD","BK4207","LU0106831901.USD","LU1267930227.SGD","LU1244550494.USD","LU0072461881.USD","LU1162221912.USD","LU0477156953.USD","LU0980610538.SGD","LU0130102774.USD","BK4566","LU2125154778.USD","BK1500","LU2236285917.USD","BK4534","LU1201861249.SGD","LU1244550221.USD","LU1506573853.SGD","LU2456880835.USD","LU0052756011.USD","LU0314106906.USD","C","BK1197","01099","LU0640798160.USD","LU2462157665.USD","IE00BSNM7G36.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621403507","title":"Sinopharm FY2025 net profit rose 3.94% to RMB 10,834 million as net cash from operating activities climbed 22.45% to RMB 14,138 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621403507","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621403507?lang=en_us&edition=fundamental","pubTime":"2026-03-23 08:51","pubTimestamp":1774227097,"startTime":"0","endTime":"0","summary":"Sinopharm FY2025 net profit rose 3.94% to RMB 10,834 million as net cash from operating activities climbed 22.45% to RMB 14,138 million. Sinopharm published a 2025 annual results presentation reporting business revenue of RMB575.17 billion, up 1.62%.Net profits were RMB10.83 billion, up 3.94%, while net profits attributable to owners of the parent were RMB7.16 billion, up 1.5%.Gross profit margin was 7.25%  and net profit margin was 1.88% .Segment revenue included pharmaceutical distribution of RMB435.39 billion  and medical device distribution of RMB115.54 billion .Retail pharmacy revenue was RMB38.38 billion  and management said wholesale-retail integration and a dual-brand strategy supported growth, while it managed lower-efficiency device businesses with long payment terms to reduce risk.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL5kWYpj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1515","BK1500","BK1197","LU1115378108.SGD","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148475248","title":"SINOPHARM Reports Annual Earnings with 1.5% Rise in Net Profit Attributable to Owners","url":"https://stock-news.laohu8.com/highlight/detail?id=1148475248","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148475248?lang=en_us&edition=fundamental","pubTime":"2026-03-23 07:23","pubTimestamp":1774221800,"startTime":"0","endTime":"0","summary":"SINOPHARM (01099) announced its annual results for the year ended December 31, 2025. The Group recorded revenue of RMB 575.168 billion, representing a decrease of 1.6% year-on-year. Profit...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1115378108.SGD","BK1197","BK1515","BK1500","01099","BK4585","BK4588","LU0640798160.USD","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621818744","title":"BRIEF-Sinopharm Group Posts FY Profit Attributable Of RMB7.16 BLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2621818744","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621818744?lang=en_us&edition=fundamental","pubTime":"2026-03-23 06:18","pubTimestamp":1774217901,"startTime":"0","endTime":"0","summary":"BRIEF-Sinopharm Group Posts FY Profit Attributable Of RMB7.16 BLNMarch 23  - Sinopharm Group Co Ltd 1099.HK:FINAL DIVIDEND OF RMB0.69 PER ORDINARY SHARE IS TO BE PROPOSEDFY PROFIT ATTRIBUTABLE RMB7.16 BILLIONFY REVENUE RMB575.17 BILLIONFurther company coverage: 1099.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260322:nFWN4080Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1197","BK1515","LU0640798160.USD","01099","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621892744","title":"Sinopharm Group proposes final dividend of RMB 0.69 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2621892744","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621892744?lang=en_us&edition=fundamental","pubTime":"2026-03-23 06:16","pubTimestamp":1774217815,"startTime":"0","endTime":"0","summary":"Shareholder approval is scheduled for June 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260322:nNDL3PQNfP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","01099","LU1115378108.SGD","BK1197","BK1515","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621410717","title":"Sinopharm Group - FY Profit Attributable RMB7.16 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2621410717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621410717?lang=en_us&edition=fundamental","pubTime":"2026-03-23 06:14","pubTimestamp":1774217671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260322:nFWN4080Z0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1115378108.SGD","BK1197","01099","LU0640798160.USD","BK1515","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621073741","title":"Sinopharm Group -  Final Dividend of RMB0.69 per Ordinary Share Is to Be Proposed","url":"https://stock-news.laohu8.com/highlight/detail?id=2621073741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621073741?lang=en_us&edition=fundamental","pubTime":"2026-03-23 06:14","pubTimestamp":1774217671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260322:nFWN4080Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","LU1115378108.SGD","BK1500","01099","BK1197","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620735379","title":"Sinopharm Group (SEHK:1099) Valuation Check As Recent Share Price Moves Draw Investor Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2620735379","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620735379?lang=en_us&edition=fundamental","pubTime":"2026-03-20 16:12","pubTimestamp":1773994379,"startTime":"0","endTime":"0","summary":"Why Sinopharm Group is on investors’ radar today\nSinopharm Group (SEHK:1099) has drawn attention after recent share price moves, with a 1-day and past-week return of a 1.0% decline, alongside mixed performance over the month and past 3 months.\nSee our latest analysis for Sinopharm Group.\nAt a share price of HK$20.84, Sinopharm Group’s recent share price return has softened over the past month, although the 90 day and year to date share price returns remain positive while longer term total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-sehk1099-valuation-check-as-recent-share-pri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-sehk1099-valuation-check-as-recent-share-pri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","LU1115378108.SGD","BK1515","BK1197","BK1500","01099","LU0640798160.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.0088},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.1801},{"period":"ytd","weight":0.0484}],"compareEarnings":[{"period":"1week","weight":0.0301},{"period":"1month","weight":0.016},{"period":"3month","weight":-0.0418},{"period":"6month","weight":-0.0006},{"period":"1year","weight":0.208},{"period":"ytd","weight":0.0094}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sinopharm Group Co Ltd is a China-based company principally engaged in the wholesale and retail of pharmaceutical and healthcare products and medical devices. The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.004643},{"month":2,"riseRate":0.588235,"avgChangeRate":0.029413},{"month":3,"riseRate":0.470588,"avgChangeRate":0.007007},{"month":4,"riseRate":0.470588,"avgChangeRate":0.022048},{"month":5,"riseRate":0.625,"avgChangeRate":-0.004548},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.005852},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015111},{"month":8,"riseRate":0.4375,"avgChangeRate":0.012101},{"month":9,"riseRate":0.4375,"avgChangeRate":-0.011177},{"month":10,"riseRate":0.647059,"avgChangeRate":0.042295},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.007287},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.004122}],"exchange":"SEHK","name":"SINOPHARM","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINOPHARM(01099) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINOPHARM,01099,SINOPHARM股票,SINOPHARM股票老虎,SINOPHARM股票老虎国际,SINOPHARM行情,SINOPHARM股票行情,SINOPHARM股价,SINOPHARM股市,SINOPHARM股票价格,SINOPHARM股票交易,SINOPHARM股票购买,SINOPHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINOPHARM(01099) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}